ASIC3 and nasopharyngeal carcinoma: On the contrary, Hamish proved that inhibition of ASIC3 would prevent the acid-induced proinflammatory and pain-related/degenerative phenotype in NPC, suggesting that ASIC3 may be a useful therapeutic target for the treatment of IVDD [18].